Zachary L Taylor
Affiliations: | 2017-2021 | Department of Pharmacology and Systems Physiology | University of Cincinnati, Cincinnati, OH |
Area:
methotrexateGoogle:
"Zachary Taylor"Parents
Sign in to add mentor| Laura B. Ramsey | grad student | 2021 | University of Cincinnati | |
| (Understanding the pharmacogenetics and pharmacokinetics of methotrexate to improve clinical care) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ibarra M, Combs R, Taylor ZL, et al. (2022) Insights from a pharmacometric analysis of HDMTX in adults with cancer: clinically relevant covariates for application in precision dosing. British Journal of Clinical Pharmacology |
| Mehta RS, Taylor ZL, Martin LJ, et al. (2021) SLCO1B1 *15 allele is associated with methotrexate-induced nausea in pediatric patients with inflammatory bowel disease. Clinical and Translational Science |
| Taylor ZL, Vang J, Lopez-Lopez E, et al. (2021) Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies. Cancers. 13 |
| Taylor ZL, Thompson LE, Bear H, et al. (2021) Toward pharmacogenetic SLCO1B1-guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model. Clinical and Translational Science |
| Taylor ZL, Mizuno T, Punt NC, et al. (2020) MTXPK.org: A clinical decision support tool evaluating high-dose methotrexate pharmacokinetics to inform post-infusion care and use of glucarpidase. Clinical Pharmacology and Therapeutics |
| Mizuno T, Dong M, Taylor ZL, et al. (2020) Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care. British Journal of Clinical Pharmacology |